Oxford Immunotec Global Profit Margin 2012-2018 | OXFD
Current and historical gross margin, operating margin and net profit margin for Oxford Immunotec Global (OXFD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Oxford Immunotec Global net profit margin as of September 30, 2018 is 147.71%.
|Oxford Immunotec Global Annual Profit Margins
|Oxford Immunotec Global Quarterly Profit Margins
||Medical Instruments Manufacturing
Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.